HDCN Article Review/Hyperlink

van Vollenhoven RF, Hahn BH, Tsokos GC, et al

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicenter RCT

Lancet (Oct) 391:1330-1339, 2018

The abstract of this paper is available from the Lancet. Click here for the abstract.
         Related Folders:

Return to Home